跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONDERO ONDANSETRON INJECTION BP 2MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
ONDERO ONDANSETRON INJECTION BP 2MG/ML
Approved
THERAPEUTIC
ONDERO ONDANSETRON INJECTION BP 2MG/ML
Aspiro Pharma Limited
🇸🇬 Health Sciences Authority
Approval Date
May 26, 2020
Approval ID
ddc6766b613f3725
Company
Aspiro Pharma Limited
Type
Therapeutic
Approval Details
Approval Id
ddc6766b613f3725
Drug Name
ONDERO ONDANSETRON INJECTION BP 2MG/ML
Product Name
ONDERO ONDANSETRON INJECTION BP 2MG/ML
Approval Number
SIN15946P
Approval Date
2020-05-26
Registrant
HETERO SINGAPORE PTE. LTD.
Licence Holder
HETERO SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
A04AA01
Atc Item Name
ondansetron
Pharma Manufacturer Name
HETERO SINGAPORE PTE. LTD.
Company Detail Path
/organization/hetero-singapore-pte-ltd
Active Ingredients
Ondansetron hydrochloride dehydrate eqv to Ondansetron
2 mg/mL
ONDANSETRON HYDROCHLORIDE DEHYDRATE EQV TO ONDANSETRON
2 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 26, 2020
Approval ID
ddc6766b613f3725
Type
Therapeutic
Back to HSA Approvals